“…2 For many individuals, there must be a long, preclinical phase of cardiac dysfunction. 3,4 Intervening before the onset of symptoms may offer the best opportunity to delay their onset, change the disease trajectory and prolong active life. This requires screening of asymptomatic people, usually those at greater risk of developing heart failure, to identify preclinical cardiac dysfunction.…”